<DOC>
	<DOCNO>NCT02244268</DOCNO>
	<brief_summary>The aim observational study identify primary BPH symptom responsible patient consult urologic practice , result prescription ALNA® , assess clincial efficacy improve occupational performance patient still employ . Additionally obtain relevant information 5-year report experience product accord requirement § 49 , para 6 German Medicines Act .</brief_summary>
	<brief_title>Study Evaluate Effect ALNA® ( Tamsulosin ) Primary Symptoms Benign Prostatic Hyperplasia</brief_title>
	<detailed_description />
	<mesh_term>Hyperplasia</mesh_term>
	<mesh_term>Prostatic Hyperplasia</mesh_term>
	<mesh_term>Tamsulosin</mesh_term>
	<criteria>Patients suffer symptomatic benign prostatic hyperplasia ( BPH ) symptoms receive ALNA® treatment include observation accord prescribe information No exclusion criterion define , prescribe information consider</criteria>
	<gender>Male</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2014</verification_date>
</DOC>